Abstract:Objective To investigate the clinical features and mutations of the FAH gene.Method Clinical records of two cases were collected,and diagnosis was made according to the diagnostic criteria of the International Organization for Rare Disorders (NORD).Genomic DNA was extracted from peripheral blood leukocytes with QIAamp(R) DNA Mini Kit.The DNA extracts were subjected to direct sequencing for 14exons together with adjacent fragments of FAH gene using ABI Prism 3730 Genetic Analyzer (Applied Biosystems,Foster City,CA) after PCR based on genomic DNA.The mutation source was verified by analyzing parents' exons corresponding to patients' mutation exons.The homology between human FAH enzyme and that of other species was surveyed using software Clustal X (European Bioinformatics Institute,Hinxton,Saffron Walde,UK).Polyphen (Polymorphism Phenotyping),available online,were used to predict possible impact of an amino acid substitution on structure and function of FAH enzyme.Polyphen calculates position-specific independent counts (PISC) scores for two amino acid variants in polymorphic position.A PISC scores that differ by ＞ 2 were regarded as indicating the probability of damaging variants.Result Patient 1 was a 5 months and 21 days-old boy who suffered from persistent diarrhea,hepatomegaly,ascites; Alpha-fetoprotein ＞ 1210 μg/L,levels of tyrosine in blood and succinylacetone in urine were 110.8 μmol/L and 83.7 μmol/L.His sister suffered from tyrosinemia type 1.Direct sequencing showed a G to A transition in CDS position 455 and 1027.He was compound heterozygous for the mutation c.455G＞ A/c.1027G ＞ A,which predicts a change from tryptophan to a stop codon (TGG＞ TAG) at position 152 (W152X) and a change from glycine to arginine (GGG ＞ AGG) at position 343 respectively.Patient 2 was a 6 year and 1 month-old girl with late-onset rickets who had signs of hepatosplenomegaly,rachitic rosary,windswept knees.Hypophosphatemia and alkaline phosphatase 1620 IU/L were detected.Alpha-fetoprotein 412.8 μg/L,levels of tyrosine in blood and succinylacetone in urine were 835.8 μmol/L and 27.48 μmol/L.Rickets did not improve after administration of calcium and vitamine D3.She is homozygous for the mutation c.1027G ＞ A/c.1027G ＞ A,which predicts G343R.The parents were mutation carriers.Analysis by Clustal X on the alignment of amino acids residual reservation among different species showed that the locative amino acid was highly conserved.Polyphen software predicted G343R was probably damaging (PISC score 3.235).Conclusion Children with tyrosinemia type 1 can have manifestations of persistent diarrhea or late-onset tickets.Physical examination can reveal hepatosplenomegaly,laboratory tests indicate markedly elevated serum concentration of alpha-fetoprotein and alkaline phosphatase in plasma and succinylacetone in urine,other members in family may have tyrosinemias or parents are consanguineous.Mutations c.455G ＞A and c.1027G ＞ A can be detected in FAH gene of Chinese children.

Consenso mexicano de tirosinemia tipo 1

Diagnosis, treatment, management and monitoring of patients with tyrosinaemia type 1: Consensus group recommendations from the German‐speaking countries

Screening for Hereditary Tyrosinemia and Genotype Analysis in Newborns

Clinical, Biochemical, and Molecular Characteristics of Filipino Patients with Tyrosinemia Type 1

Oxidative Stress Associated With Increased Reactive Nitrogen Species Generation in the Liver and Kidney Caused by a Major Metabolite Accumulating in Tyrosinemia Type 1

Emotional and behavioural functioning in children with tyrosinaemia type 1

Identification and Functional Characterization of a Novel Homozygous Intronic Variant in the Fumarylacetoacetate Hydrolase Gene in a Chinese Patient with Tyrosinemia Type 1.

In vivo dissection of the mouse tyrosine catabolic pathway with CRISPR-Cas9 identifies modifier genes affecting hereditary tyrosinemia type 1

Neurocognitive outcome and mental health in children with Tyrosinemia type 1 and Phenylketonuria: A comparison between two genetic disorders affecting the same metabolic pathway

Utility for Therapeutic Management

[Clinical Features and Genetic Analysis of a Child with Acute Form of Tyrosinemia Type I Due to a Novel Variant of FAH Gene].

[Expert Consensus for the Diagnosis and Treatment of Glutaricacidemia Type 1].

Analysis of clinical data and genetic mutations in three Chinese patients with tyrosinemia type Ⅰ

The outcome of seven patients with hereditary tyrosinemia type 1

Application of succinylacetone levels measurement in the blood and urine in the diagnosis of tyrosinemia type 1

Mutation analysis of FAH gene in patients with tyrosinemia type 1

Corneal Lesion As the Initial Manifestation of Tyrosinemia Type II

Living-donor Liver Transplantation for Children with Tyrosinemia Type I.

The Analysis of Therapeutic Effect of Nitisinone in Two Patients with Tyrosinemia Typeⅰand Review of Literature

Visceral pathology of hereditary tyrosinemia type I

Mutation spectrum of Tyrosinemia type I in Iran, A retrospective cohort study